Search research articles
Contact Us
Filters
Showing results (51-60 of 139) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells
Michael Hudecek, Maria-Teresa Lupo-Stanghellini, Paula L Kosasih, et al.
Journal for Immunotherapy of Cancer
|
April 29, 2025
Tailoring CAR surface density and dynamics to improve CAR-T cell therapy
Ana Hinckley-Boned, Carmen Barbero-Jiménez, Maria Tristán-Manzano, et al.
Cancer Immunology Research
|
September 13, 2014
The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity
Michael Hudecek, Daniel Sommermeyer, Paula L Kosasih, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 20, 2017
Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells
Michael Hudecek, Tea Gogishvili, Razieh Monjezi, et al.
Science Translational Medicine
|
July 5, 2019
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Katrin Mestermann, Theodoros Giavridis, Justus Weber, et al.
Theranostics
|
February 24, 2022
CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism
Juliane Medler, Kirstin Kucka, Vinicio Melo, et al.
Gene Therapy
|
April 13, 2021
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma
Sabrina Prommersberger, Michael Reiser, Julia Beckmann, et al.
Cancer Immunology Research
|
October 31, 2014
Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells
Carolina Berger, Daniel Sommermeyer, Michael Hudecek, et al.
Cancers
|
November 27, 2024
Cellular Therapies for Multiple Myeloma: Engineering Hope
Sarah Vera-Cruz, Maria Jornet Culubret, Verena Konetzki, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2020
<b>Inhibition of TGF-</b>β-<b>receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer</b>
Tanja Stüber, Razieh Monjezi, Lars Wallstabe, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 139) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells
Michael Hudecek, Maria-Teresa Lupo-Stanghellini, Paula L Kosasih, et al.
Journal for Immunotherapy of Cancer
|
April 29, 2025
Tailoring CAR surface density and dynamics to improve CAR-T cell therapy
Ana Hinckley-Boned, Carmen Barbero-Jiménez, Maria Tristán-Manzano, et al.
Cancer Immunology Research
|
September 13, 2014
The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity
Michael Hudecek, Daniel Sommermeyer, Paula L Kosasih, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 20, 2017
Minicircle-Based Engineering of Chimeric Antigen Receptor (CAR) T Cells
Michael Hudecek, Tea Gogishvili, Razieh Monjezi, et al.
Science Translational Medicine
|
July 5, 2019
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Katrin Mestermann, Theodoros Giavridis, Justus Weber, et al.
Theranostics
|
February 24, 2022
CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism
Juliane Medler, Kirstin Kucka, Vinicio Melo, et al.
Gene Therapy
|
April 13, 2021
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma
Sabrina Prommersberger, Michael Reiser, Julia Beckmann, et al.
Cancer Immunology Research
|
October 31, 2014
Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells
Carolina Berger, Daniel Sommermeyer, Michael Hudecek, et al.
Cancers
|
November 27, 2024
Cellular Therapies for Multiple Myeloma: Engineering Hope
Sarah Vera-Cruz, Maria Jornet Culubret, Verena Konetzki, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2020
<b>Inhibition of TGF-</b>β-<b>receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer</b>
Tanja Stüber, Razieh Monjezi, Lars Wallstabe, et al.
Page
of 14